Follow the 삼성생명 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Banks sector, 삼성생명 has logged 25 insider filings. Market capitalisation: €50,999.2bn. The latest transaction was filed on 22 May 2026 (Other). Among the most active insiders: 삼성물산. Every trade is accessible without an account.
25
Insider Decl.
n/a
Thresholds
n/a
5 ops.
Buy Volume
n/a
13 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 삼성생명 Buy (bullish), based on 17 analysts. Average price target: ₩411,559.
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 9,512 of 28,134 companies
59.5
score / 100
Value
70
Quality
49
FCF yld10%
Earn yld4.7%
EV/EBITDA8.9x
ROE5.3%
Gross mgn·
Net mgn8.1%
Debt/EBITDA2.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.